Association of Vitamin D Deficiency with Cardiovascular Disease Among Saudi Patients in Saudi Arabia

Salem Jabbar, Hamdan Alghamdi, Eltigani O. M. Omer, Mubashir Zafar, Hatem Khader, Ibrahim Herzallah

Abstract


Background: Vitamin D deficiency has a far‑reaching impact on several metabolic functions including cardiovascular health. This study aimed to test the association of serum 25 [OH]‑vitamin D3 levels among cardiovascular disease (i.e., hypertension and ischemic heart disease) patients.

Methods: A cross‑sectional study was conducted among 360 participants from the tertiary care hospital. The simple random technique was used to select the participants. Only Saudi nationals were included in the study. Sociodemographic information, nutritional status, biochemical parameter (lipid profile, blood glucose level), and questions relating to cardiovascular disease were collected from the hospital record through data collection sheet. Serum Vit D level was determined by serum 25 (OH) blood test. Statistical package for social science (SPSS) software version 24 was used for data analysis. Binary logistic regression model was fitted to indentify the associated factors of vitamin D deficiency among cardiovascular disease patients.

Results: Approximately 40.6% and 27.8% of study participants had vitamin D deficiency and insufficiency, respectively. After adjustment of covariates, among cardiac patients, vitamin D deficiency was associated with ischemic heart disease (OR 2.24, 95% CI 1.11–4.52), and blood triglyceride level (OR 2.27, 95% CI 1.22–4.22).

Conclusions: Vitamin D deficiency and insufficiency are associated with ischemic heart disease, hyperglycemia, and hypertriglyceridemia. There is a need for the screening of cardiovascular disease patients for vitamin D levels.


Keywords


Abnormality; blood; heart; patients; vitamin D

Full Text:

PDF

References


Kheiri B, Abdalla A, Osman M, Ahmed S, Hassan M, Bachuwa G. Vitamin D deficiency and risk of cardiovascular diseases: A narrative review. Clinical Hypertension 2018;24:9.2. Beveridge LA, Struthers AD, Khan F, Jorde R, Scragg R, Macdonald HM, et al. Effect of vitamin D supplementation on blood pressure: A systematic review and meta‑analysis incorporating individual. Patient data. JAMA Intern Med 2015;175:745‑54.3. Kimlin MG. Geographic location and vitamin D synthesis. Mol Aspects Med 2008;29:453‑61.4. Zittermann A. Vitamin D in preventive medicine: Are we ignoring the evidence? Br J Nutr 2003;89:552‑72.5. Holick MF. Vitamin D: Importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004;79:362‑71.6. Parker J, Hashmi O, Dutton D, Mavrodaris A, Stranges S, Kandala NB, et al. Levels of vitamin D and cardiometabolic disorders: Systematic review and meta‑analysis. Maturitas 2010;65:225‑36.7. Lappe JM, Travers‑Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial. Am J Clin Nutr 2007;85:1586‑91.8. Pappa HM, Gordon CM, Saslowsky TM, Zholudev A, Horr B, Shih MC, et al. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 2006;118:1950‑61.9. Al Shaikh AM, Abaalkhail B, Soliman A, Kaddam I, Aseri K, Al Saleh Y, et al. Prevalence of vitamin D deficiency and calcium homeostasis in Saudi children. J Clin Res Pediatr Endocrinol 2016;8:461‑7.10. Tamez H, Kalim S, Thadhani RI. Does vitamin D modulate blood pressure? Curr Opin Nephrol Hypertens 2013;22:204‑9.11. Scragg RK, Camargo CA Jr, Simpson RU. Relation of serum 25‑hydroxyvitamin D to heart rate and cardiac work (from the national health and nutrition examinations surveys). Am J Cardiol 2010;105:122‑8.

Schroten NF, Ruifrok WP, Kleijn L, Dokter MM, Silljé HH, Lambers Heerspink HJ, et al. Short‑term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: An open‑label, blinded end point, randomized prospective trial (VitD‑CHF trial). Am Heart J 2013;166:357‑64.e2.13. Liu L, Chen M, Hankins SR, Nùñez AE, Watson RA, Weinstock PJ, et al.; Drexel Cardiovascular Health Collaborative Education, Research, and Evaluation Group. Serum 25‑hydroxyvitamin D concentration and mortality from heart failure and cardiovascular disease, and premature mortality from all‑cause in United States adults. Am J Cardiol 2012;110:834‑9.14. Ross AC, Taylor CL, Yaktine AL, Del Valle HB. Dietary Reference Intake for Calcium and Vitamin D. Washington, DC, USA: National Academies Press; 2011.15. Alkerwi A, Sauvageot N, Gilson G, Stranges S. Prevalence and correlates of vitamin D deficiency and insufficiency in Luxembourg adults: Evidence from the observation of cardiovascular risk factors (ORISCAV‑LUX) study. Nutrients 2015;7:6780‑96.16. Zhang R, Li B, Gao X, Tian R, Pan Y, Jiang Y, et al. Serum 25‑hydroxyvitamin D and the risk of cardiovascular disease: Dose‑response meta‑analysis of prospective studies. Am J Clin Nutr 2017;105:810‑9.17. Al‑Khalidi B, Kimball SM, Rotondi MA, Ardern CI. Standardized serum 25‑hydroxyvitamin D concentrations are inversely associated with cardiometabolic disease in U.S. adults: A cross‑sectional analysis of NHANES, 2001‑2010. Nutr J 2017;16:16.18. Kendrick J, Targher G, Smits G, Chonchol M. 25‑Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the third national health and nutrition examination survey. Atherosclerosis 2009;205:255‑60.19. Ke L, Mason RS, Mpofu E, Vingren JL, Li Y, Graubard BI, et al. Hypertension and other cardiovascular risk factors are associated with vitamin D deficiency in an urban Chinese population: A short report. J Steroid Biochem Mol Biol 2017;173:286‑91.20. Marniemi J, Alanen E, Impivaara O, Seppänen R, Hakala P, Rajala T, et al. Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects. Nutr Metab Cardiovasc Dis 2005;15:188‑97.21. Clark AN, Mankikar GD, Gray I. Diogenes syndrome: A clinical study of gross neglect in old age. Lancet 1975;305:366‑8.22. Toloza SM, Cole DE, Gladman DD, Ibanez D, Urowitz MB. Vitamin D insufficiency in a large female SLE cohort. Lupus 2010;19:13‑9.23. Pilz S, Verheyen N, Grübler MR, Tomaschitz A, März W. Vitamin D and cardiovascular disease prevention. Nature Reviews Cardiology 2016;13:404.24. Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Diabetologia 2005;48:1247‑57.25. Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Rheum Dis Clin North Am 2012;38:179‑206.26. Reinehr T, de Sousa G, Alexy U, Kersting M, Andler W. Vitamin D status and parathyroid hormone in obese children before and after weight loss. Eur J Endocrinol 2007;157:225‑32.27. Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH. Low circulating vitamin D in obesity. Calcif Tissue Int 1988;43:199‑201.28. Sneve M, Figenschau Y, Jorde R. Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol 2008;159:675‑84.29. Forman JP, Bischoff‑Ferrari HA, Willett WC, Stampfer MJ, Curhan GC. Vitamin D intake and risk of incident hypertension: Results from three large prospective cohort studies. Hypertension 2005;46:676‑82.30. Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C. Effects of a short‑term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001;86:1633‑7.31. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25‑dihydroxyvitamin D(3) is a negative endocrine regulator of the renin‑angiotensin system. J Clin Invest 2002;110:229‑38.